SpyBiotech receives grant from the Bill & Melinda Gates Foundation to advance novel SpyVector Platform.
- SpyBiotech has received a grant of $4m from the Bill & Melinda Gates Foundation to further develop its novel vaccine technology.
- This project will harness SpyBio’s ‘plug and display’ technology to design a broadly cross-protective coronavirus vaccine.